QUOTE AND NEWS
StreetInsider.com  Mar 7  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/NanoViricides+%28NNVC%29+Denies+SeekingAlpha+Rumor+It%27s+Being+Acquired/9258108.html for the full story.
DailyFinance  Feb 14  Comment 
NanoViricides, Inc. (NYSE MKT:NNVC) (the “Company”) has demanded from Seeking Alpha the removal of a damaging, baseless and inaccurate article posted by a person who was shorting NNVC common stock. It is obvious...
Benzinga  Feb 11  Comment 
NanoViricides, Inc. (NYSE: NNVC) (the “Company”) responded to a baseless and inaccurate article posted on Seeking Alpha, a stock market analysis website, which obtains content from its members. The article was filed anonymously by a person...
StreetInsider.com  Feb 11  Comment 
The following is a list of notable articles to help get you through the lunch hour: NanoViricides (NNVC) Slammed by Short Seller -> Read this! Sony (SNE) Pushes Boundaries of Marketing with Latest Walkman Effort -> Read this! U.S. E-Commerce...
SeekingAlpha  Feb 11  Comment 
By Pump Terminator: PLEASE SEE FULL DISCLOSURE IN OUR PROFILE Aside from sounding like the name of another terrible Keanu Reeves movie, Nanoviricides (NNVC) is the worst US reverse merger we have ever seen. NNVC is so obviously a vehicle designed...
DailyFinance  Dec 23  Comment 
WEST HAVEN, CT -- (Marketwired) -- 12/23/13 -- NanoViricides, Inc. (NYSE MKT: NNVC) is a development stage company that is creating special purpose nanomaterials to destroy viruses in and on the body. The Company today announced that Michael...
DailyFinance  Dec 18  Comment 
Eugene Seymour to Be Interviewed Live Dec 19th on Traders Financial Network Radio Show by Host Michael YorbaWEST HAVEN, CT -- (Marketwired) -- 12/18/13 -- NanoViricides, Inc. (NYSE MKT: NNVC) is a development stage company that is creating...
DailyFinance  Dec 2  Comment 
NanoViricides, Inc. (NYSE MKT:NNVC) (the "Company") reports that it has received results of detailed lab analysis studies from the initial non-GLP toxicology studies of intravenously administered FluCide™. No overt adverse...
StreetInsider.com  Nov 11  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/NanoViricides+%28NNVC%29+Higher+after+Orphan+Drug+Designation+in+Europe/8869202.html for the full story.
Benzinga  Oct 21  Comment 
NanoViricides (NYSE: NNVC) reports that its optimized injectable FluCide drug candidate was found to be well tolerated in a non-GLP small animal safety/toxicology study. This study is an important step in the drug development...





 

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki